ARCHIVES

Scripps, Sandoz Deal Becomes Case Study As NI Rethinks Sponsored Research

This article is from The Cancer Letter archive.

Vol. 20 No. 04 | January 28, 1994

Download PDF Visit The Full Archive

Related Articles

The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data

September 25, 1998

New CIDAC RFP Limits Recompetition To Small Business Firms

January 6, 1984

Disease Oriented Programs Must Be Coordinated: Rabson

October 15, 1976

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

In Brief: Susan Hubbard Names Director Of International Cancer information Center; Includeds ICRDB, PDQ

September 14, 1984

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004